全球血液学诊断市场规模、份额、趋势和成长分析报告（2026-2034年）

预计血液诊断市场将从 2025 年的 44 亿美元成长到 2034 年的 82.1 亿美元，2026 年至 2034 年的复合年增长率为 7.18%。

由于对精确血球计数和疾病检测的需求不断增长，全球血液诊断市场正经历显着增长。血液分析仪和试剂广泛应用于医院和诊断实验室，用于识别贫血、感染疾病和血液癌症等疾病。医疗保健服务的普及和常规健康检查项目的扩展，也推动了市场的稳定成长。

关键成长要素包括慢性病和感染疾病病率的上升、自动化分析仪的技术进步以及检查室自动化的发展。诊断准确性的提高和结果报告的快速反应提升了临床决策的品质。新兴国家医疗基础设施的扩张也促进了市场成长。

随着个人化医疗和预防医学的日益普及，市场前景依然强劲。先进分析技术和人工智慧解读工具的整合将提升诊断效率。检查室现代化改造投资的增加预计将创造新的机会。随着全球医疗保健标准的提升，血液诊断市场预计将持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球血液学诊断市场：依产品划分

• 市场分析、洞察与预测
• 分析设备（分析仪、流式细胞仪等）
• 耗材（试剂、染色剂及其他配件）

第五章：全球血液学诊断市场：依检测方式划分

• 市场分析、洞察与预测
• 血球计数
• 血小板功能
• 血红素
• 血球容积比

第六章：全球血液学诊断市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 诊断实验室
• 其他的

第七章 全球血液学诊断市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和分销通路合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott
  • Beckman Coulter Inc
  • Sysmex Corporation
  • Horiba
  • Bio-Rad Lboratories
  • Siemens Healthineers AG
  • F. Hoffmann-La Roche Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • Nihon Kohden Corporation
  • EKF Diagnostics

The Hematology Diagnostics Market size is expected to reach USD 8.21 Billion in 2034 from USD 4.40 Billion (2025) growing at a CAGR of 7.18% during 2026-2034.

The Global Hematology Diagnostics Market has experienced significant growth due to rising demand for accurate blood testing and disease detection. Hematology analyzers and reagents are widely used in hospitals and diagnostic laboratories for identifying conditions such as anemia, infections, and blood cancers. Increasing healthcare access and routine health screening programs have supported steady market expansion.

Major drivers include growing prevalence of chronic and infectious diseases, technological advancements in automated analyzers, and rising laboratory automation. Improved diagnostic accuracy and faster turnaround times enhance clinical decision-making. Expanding healthcare infrastructure in emerging economies further contributes to market growth.

Future prospects remain strong as personalized medicine and preventive healthcare gain traction. Integration of advanced analytics and AI-based interpretation tools will enhance diagnostic efficiency. Growing investments in laboratory modernization will create new opportunities. As global healthcare standards improve, the hematology diagnostics market is expected to witness sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Instrument (Analyzers, Flow Cytometers, Others)
• Consumables (Reagents, Stains, Others Accessories)

By Test

• Blood count
• Platelet function
• Hemoglobin
• Hematocrit

By End Use

• Hospitals
• Diagnostic labs
• Others

COMPANIES PROFILED

• Abbott, Beckman Coulter Inc, Sysmex Corporation, Horiba, BioRad Lboratories, Siemens Healthineers AG, F HoffmannLa Roche Ltd, Shenzhen Mindray BioMedical Electronics Co Ltd, Nihon Kohden Corporation, EKF Diagnostics

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instrument (Analyzers, Flow Cytometers, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables (Reagents, Stains, Others Accessories) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET: BY TEST 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test
• 5.2. Blood count Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Platelet function Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hemoglobin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Hematocrit Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Test
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Test
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Test
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Test
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Test
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEMATOLOGY DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott
  • 9.2.2 Beckman Coulter Inc
  • 9.2.3 Sysmex Corporation
  • 9.2.4 Horiba
  • 9.2.5 Bio-Rad Lboratories
  • 9.2.6 Siemens Healthineers AG
  • 9.2.7 F. Hoffmann-La Roche Ltd
  • 9.2.8 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • 9.2.9 Nihon Kohden Corporation
  • 9.2.10 EKF Diagnostics